Contrasting features of MDR phenotype in leukemias by using two fluorochromes: Implications for clinical practice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Contrasting features of MDR phenotype in leukemias by using two fluorochromes: Implications for clinical practice

Published:2007-04 Issue:4 Volume:31 Page:445-454
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Vasconcelos Flavia C.,Cavalcanti Geraldo B.,Silva Karina L.,de Meis Ernesto,Kwee Jolie K.,Rumjanek Vivian M.,Maia Raquel C.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference50 articles.

1. Mechanisms of cancer drug resistance;Gottesman;Annu Ver Med,2002

2. Expression of breast cancer resistance protein in blast cells from patients with acute leukaemia;Ross;Blood,2000

3. Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance;Reed;Curr Opin Oncol,1995

4. The inhibitors of apoptosis: there is more to life than Bcl2;Liston;Oncogene,2003

5. Glutathione Transferases;Hayes;Annu Rev Pharmacol Toxicol,2005

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CO-RELATION OF P-GLYCOPROTEIN AND PLASMA IMATINIB IN IMATINIB RESPONDERS AND NON-RESPONDERS PATIENTS WITH CHRONIC MYELOID LEUKAEMIA;International Journal of Applied Pharmaceutics;2023-11-07

2. Fluorescence-based methods for studying activity and drug-drug interactions of hepatic solute carrier and ATP binding cassette proteins involved in ADME-Tox;Biochemical Pharmacology;2023-03

3. P‐glycoprotein and multidrug resistance‐associated protein‐1 expression in acute myeloid leukemia: Biological and prognosis implications;International Journal of Laboratory Hematology;2020-05-26

4. Inhibition of glycosphingolipid biosynthesis reverts multidrug resistance by differentially modulating ABC transporters in chronic myeloid leukemias;Journal of Biological Chemistry;2020-05

5. Age, gender and efflux transporter activity influence imatinib efficacy in chronic myeloid leukemia patients;Leukemia Research;2019-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3